LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Informatics Software Application Challenges Researchers to "Ask for Knowledge from Data”

By LabMedica International staff writers
Posted on 16 Sep 2009
Print article
New data integration and knowledge software can be applied to visualizing and confirming data-driven hypotheses.

IO Informatics, Inc. (Berkeley, CA, USA), a provider of semantically-enabled life science/healthcare data integration and knowledge software, revealed its new innovative knowledge application, Applied Semantic Knowledgebase (ASK), during a presentation at the recent GTCBio "Rediscovering Biomarkers” Conference, held in San Diego, CA, USA, in August 2009.

Bob Stanley, IO Informatics president and CEO, told the conference attendees, "ASK allows you to move beyond traditional data capture and integration to realize practical value from the knowledge contained in your data. It provides a collection of specific models, built directly from your research, which can be applied to visualizing and validating data-driven hypotheses, as well as for knowledge-based screening and decision-making. ASK gives you a decisive competitive advantage in many areas, such as biomarker-based predictive biology and personalized medicine, including, but not limited to, target profile creation and validation, compound efficacy and promiscuity screening, toxicity profiling and detection, disease signature detection, predictive clinical trials pre-screening, and patient stratification.”

Mr. Stanley went on to clarify how ASK is delivered via the Sentient software suite and is a combination of three of its core technologies: the Sentient software framework for data access and integration; state-of-the-art Semantic methods and applications; and innovative SPARQL array tools. The combination of these technologic capabilities provides researchers with the ability to capture, access, organize, and apply the knowledge contained in their data, in order to solve critical scientific and business challenges.

"Our goal as your partners in discovery,” Mr. Stanley explained, "is to apply our experience and expertise in both software and informatics methods relating to your specific research interests, so that you can obtain and apply the answers you need to solve your complex scientific and related business questions.”

Building on its advanced data access and integration capabilities, Sentient applies semantic patterns to create predictive network models using virtually any combination of internal experimental data and/or external published information. These patterns apply semantic SPARQL query technology to build complex searches across multiple information sets. SPARQL is a new type of semantic search technology capable of detecting patterns within and between different data types and relationships, even if the initial datasets are not formally joined under any common database schema or data federation method.

These patterns or models are then placed in an ASK which is unique to the scientists research focus. The researcher is then able to exploit the knowledge contained within the ASK, by querying the models themselves or by additionally creating new datasets for deeper investigation and analysis. "This transformational technology,” concluded Mr. Stanley, "makes it possible to actively leverage previously disconnected data--creating valuable knowledge that can be used to deliver a revolutionary set of applications for the life-science industry and personalized medicine.”

IOI develops software for data integration and knowledge applications. Its Semantically-enabled Sentient software suite allows life science, biotechnology, pharmaceutical, and medical researchers to structure and define complex data relationships across data sources, view these relationships, query them, and capitalize on them--all within a secure, compliant, auditable framework that helps organizations accumulate and utilize knowledge.

Related Links:

IO Informatics


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more